Literature DB >> 24670887

Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD.

Minerva M Carrasquillo1, Qurat ul Ain Khan, Melissa E Murray, Siddharth Krishnan, Jeremiah Aakre, V Shane Pankratz, Thuy Nguyen, Li Ma, Gina Bisceglio, Ronald C Petersen, Steven G Younkin, Dennis W Dickson, Bradley F Boeve, Neill R Graff-Radford, Nilüfer Ertekin-Taner.   

Abstract

OBJECTIVE: To investigate association of genetic risk factors for late-onset Alzheimer disease (LOAD) with risk of posterior cortical atrophy (PCA), a syndrome of visual impairment with predominant Alzheimer disease (AD) pathology in posterior cortical regions, and with risk of "posterior AD" neuropathology.
METHODS: We assessed 81 participants with PCA diagnosed clinically and 54 with neuropathologic diagnosis of posterior AD vs 2,523 controls for association with 11 significant single nucleotide polymorphisms (SNPs) from published LOAD risk genome-wide association studies.
RESULTS: There was highly significant association with APOE ε4 and increased risk of PCA (p = 0.0003, odds ratio [OR] = 3.17) and posterior AD (p = 1.11 × 10(-17), OR = 6.43). No other locus was significant after corrections for multiple testing, although rs11136000 near CLU (p = 0.019, OR = 0.60) and rs744373 near BIN1 (p = 0.025, OR = 1. 63) associated nominally significantly with posterior AD, and rs3851179 at the PICALM locus had significant association with PCA (p = 0.0003, OR = 2.84). ABCA7 locus SNP rs3764650, which was also tested under the recessive model because of Hardy-Weinberg disequilibrium, also had nominally significant association with PCA risk. The direction of association at APOE, CLU, and BIN1 loci was the same for participants with PCA and posterior AD. The effects for all SNPs, except rs3851179, were consistent with those for LOAD risk.
CONCLUSIONS: We identified a significant effect for APOE and nominate CLU, BIN1, and ABCA7 as additional risk loci for PCA and posterior AD. Our findings suggest that at least some of the genetic risk factors for LOAD are shared with these atypical conditions and provide effect-size estimates for their future genetic studies.

Entities:  

Mesh:

Year:  2014        PMID: 24670887      PMCID: PMC4001196          DOI: 10.1212/WNL.0000000000000335

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus.

Authors:  D M Nielsen; M G Ehm; B S Weir
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

2.  Posterior cortical atrophy. Neuropathologic correlations.

Authors:  J Victoroff; G W Ross; D F Benson; M A Verity; H V Vinters
Journal:  Arch Neurol       Date:  1994-03

3.  Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions.

Authors:  Minerva M Carrasquillo; Olivia Belbin; Talisha A Hunter; Li Ma; Gina D Bisceglio; Fanggeng Zou; Julia E Crook; V Shane Pankratz; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Zbigniew K Wszolek; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Kevin Morgan; Steven G Younkin
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.

Authors:  M H Rosenbloom; A Alkalay; N Agarwal; S L Baker; J P O'Neil; M Janabi; I V Yen; M Growdon; J Jang; C Madison; E C Mormino; H J Rosen; M L Gorno-Tempini; M W Weiner; B L Miller; W J Jagust; G D Rabinovici
Journal:  Neurology       Date:  2011-04-27       Impact factor: 9.910

5.  CSF biomarkers in posterior cortical atrophy.

Authors:  J Seguin; M Formaglio; A Perret-Liaudet; I Quadrio; Y Tholance; O Rouaud; C Thomas-Anterion; B Croisile; H Mollion; O Moreaud; M Salzmann; A Dorey; M Bataillard; M-H Coste; A Vighetto; P Krolak-Salmon
Journal:  Neurology       Date:  2011-04-27       Impact factor: 9.910

6.  Progressive posterior cortical dysfunction: a clinicopathologic series.

Authors:  J A Renner; J M Burns; C E Hou; D W McKeel; M Storandt; J C Morris
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

7.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Fanggeng Zou; V Shane Pankratz; Samantha L Wilcox; Li Ma; Louise P Walker; Samuel G Younkin; Curtis S Younkin; Linda H Younkin; Gina D Bisceglio; Nilufer Ertekin-Taner; Julia E Crook; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin
Journal:  Nat Genet       Date:  2009-01-11       Impact factor: 38.330

8.  Cognitive phenotypes in Alzheimer's disease and genetic risk.

Authors:  Julie S Snowden; Cheryl L Stopford; Camille L Julien; Jennifer C Thompson; Yvonne Davidson; Linda Gibbons; Antonia Pritchard; Corinne L Lendon; Anna M Richardson; Anoop Varma; David Neary; David Mann
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study.

Authors:  Minerva M Carrasquillo; Olivia Belbin; Talisha A Hunter; Li Ma; Gina D Bisceglio; Fanggeng Zou; Julia E Crook; V Shane Pankratz; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Zbigniew K Wszolek; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Peter Passmore; Kevin Morgan; Steven G Younkin
Journal:  Mol Neurodegener       Date:  2011-07-28       Impact factor: 14.195

View more
  28 in total

1.  [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Nirubol Tosakulwong; Stephen D Weigand; Mary Machulda; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; David T Jones; Daniel A Drubach; David S Knopman; Bradley F Boeve; Nilüfer Ertekin-Taner; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  Ann Neurol       Date:  2018-02-06       Impact factor: 10.422

Review 2.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

3.  Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.

Authors:  Gregory S Day; Brian A Gordon; Kelley Jackson; Jon J Christensen; Maria Rosana Ponisio; Yi Su; Beau M Ances; Tammie L S Benzinger; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Apr-Jun       Impact factor: 2.703

4.  Association of Alzheimer's disease GWAS loci with MRI markers of brain aging.

Authors:  Ganesh Chauhan; Hieab H H Adams; Joshua C Bis; Galit Weinstein; Lei Yu; Anna Maria Töglhofer; Albert Vernon Smith; Sven J van der Lee; Rebecca F Gottesman; Russell Thomson; Jing Wang; Qiong Yang; Wiro J Niessen; Oscar L Lopez; James T Becker; Thanh G Phan; Richard J Beare; Konstantinos Arfanakis; Debra Fleischman; Meike W Vernooij; Bernard Mazoyer; Helena Schmidt; Velandai Srikanth; David S Knopman; Clifford R Jack; Philippe Amouyel; Albert Hofman; Charles DeCarli; Christophe Tzourio; Cornelia M van Duijn; David A Bennett; Reinhold Schmidt; William T Longstreth; Thomas H Mosley; Myriam Fornage; Lenore J Launer; Sudha Seshadri; M Arfan Ikram; Stephanie Debette
Journal:  Neurobiol Aging       Date:  2015-01-06       Impact factor: 4.673

Review 5.  Case Studies Illustrating Focal Alzheimer's, Fluent Aphasia, Late-Onset Memory Loss, and Rapid Dementia.

Authors:  Gamze Balci Camsari; Melissa E Murray; Neill R Graff-Radford
Journal:  Neurol Clin       Date:  2016-06-03       Impact factor: 3.806

6.  Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.

Authors:  Weidong Ji; Lanling Xu; Haiyun Zhou; Suishan Wang; Yan Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Authors:  Xiaoliu Dong; Li Zhang; Qingling Meng; Qiuyan Gao
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

8.  Evaluating pathogenic dementia variants in posterior cortical atrophy.

Authors:  Minerva M Carrasquillo; Imelda Barber; Sarah J Lincoln; Melissa E Murray; Gamze Balci Camsari; Qurat Ul Ain Khan; Thuy Nguyen; Li Ma; Gina D Bisceglio; Julia E Crook; Steven G Younkin; Dennis W Dickson; Bradley F Boeve; Neill R Graff-Radford; Kevin Morgan; Nilüfer Ertekin-Taner
Journal:  Neurobiol Aging       Date:  2015-10-08       Impact factor: 4.673

9.  Meta-analysis of the association between CD33 and Alzheimer's disease.

Authors:  Yu-Ting Jiang; Hai-Yan Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

10.  ABCA7 genotype altered Aβ levels in cerebrospinal fluid in Alzheimer's disease without dementia.

Authors:  Fang-Chen Ma; Yu Zong; Hui-Fu Wang; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.